Development of reliable screening systems for drugs which regulate bone resorption : In vitro assay systems for osteoclast formation and function.

开发调节骨吸收药物的可靠筛选系统:破骨细胞形成和功能的体外测定系统。

基本信息

  • 批准号:
    05557082
  • 负责人:
  • 金额:
    $ 6.59万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1995
  • 项目状态:
    已结题

项目摘要

Using a co-culture system of mouse osteoblastic cells and bone marrow cells, we have established reliable assay systems for examining osteoclast development and function. In a assay system for osteoclast development, chronological changes in phenotypic expression by postmitotic osteoclast precursors were examined during their differentiation into osteoclasts. The mechanism of action of bone resorption-inhibiting agents such as calcitonin and bisphosphonates in bone resorption was also examined in the present study using those assay systems.(1) Characteristics of postmitotic precursor cells that differentiate into osteoclastsCharacteristics of osteoclast precursors that differentiate into osteoclasts were examined using a co-culture system of mouse osteoblastic cells and bone marrow cells. Postmitotic osteoclast precursors were mononuclear cells which expressed macrophage-associated phenotypes such as nonspecific esterase (NSE), Mac-1 and Mac-2. Some of the macrophage-associated phenoty … More pes in osteoclast precursors disappeared rapidly during their differentiation into osteoclasts.(2) Establishment of assay systems for examining osteoclast functionWe have previously established a method for preparing a large number of functionally active osteoclasts from cocultures of mouse osteoblastic cells and bone marrow cells. To examine effects of bone resorption-regulatory factors on osteoclast function, we have developed assay systems for pit formation and actin ring formation using osteoclasts formed in vitro. We have shown that osteclast function is regulated by several signaling patheays mediated by cyclic AMP dependentprotein kinase, tyrosine kiases, phosphatidylinositol-3 kinase, and small GTP binding protein, rho.Effects of calcitonin and bisphosphonates on osteoclastic bone resorptionThe mechanism of inhibitory action of calcitonin and bisphosphonates on bone resorption was examined in established assay systems as described above. Both calcitonin and bisphosphonates inhibited pit forming activity of osteoclasts placed on dentine slices. Only polarized osteoclasts having ruffled borders incorporated bisphosphonates, which inhibited tyrosine phosphatases and disrupted actin rings of osteoclasts. Calcitonin also induced marked changes in osteoclast morphology including disruption of actin rings. This effect was observed in both polarized and non-polarized osteoclasts. Thus, both calcitonin and bisphosphonates suppress osteoclast function, but their mechanisms of action are quite different from each other. Less
利用小鼠成骨细胞和骨髓细胞的共培养系统,我们建立了可靠的检测破骨细胞发育和功能的检测系统。在破骨细胞发育的测定系统中,在有丝分裂后破骨细胞前体分化成破骨细胞的过程中,检查了破骨细胞表型表达的时间变化。在本研究中,还使用这些测定系统检查了骨吸收抑制剂(如降钙素和双膦酸盐)在骨吸收中的作用机制。(1)分化为破骨细胞的有丝分裂后前体细胞的特征使用小鼠成骨细胞和骨髓细胞的共培养系统检测分化为破骨细胞的破骨细胞前体细胞的特征。有丝分裂后破骨细胞前体细胞是表达巨噬细胞相关表型如非特异性酯酶(NSE)、Mac-1和Mac-2的单核细胞。一些与巨噬细胞相关的表型 ...更多信息 破骨细胞前体细胞在向破骨细胞分化的过程中PES迅速消失。(2)破骨细胞功能检测体系的建立我们以前建立了一种从小鼠成骨细胞和骨髓细胞的共培养物中制备大量功能活性破骨细胞的方法。为了研究骨吸收调节因子对破骨细胞功能的影响,我们已经开发了使用体外形成的破骨细胞进行小凹形成和肌动蛋白环形成的测定系统。我们已经证明破骨细胞的功能是由几种信号通路调节的,这些通路由环AMP依赖性蛋白激酶、酪氨酸激酶、磷脂酰肌醇-3激酶和小GTP结合蛋白rho介导。降钙素和二膦酸盐对破骨细胞骨吸收的影响降钙素和二膦酸盐对骨吸收的抑制作用的机制在上述建立的测定系统中进行了研究。降钙素和双磷酸盐抑制窝的破骨细胞放置在牙本质切片的活动。只有极性破骨细胞有皱褶的边界纳入双磷酸盐,抑制酪氨酸磷酸酶和破坏肌动蛋白环的破骨细胞。降钙素也诱导破骨细胞形态学的显着变化,包括破坏肌动蛋白环。在极化和非极化破骨细胞中均观察到这种效应。因此,降钙素和双磷酸盐抑制破骨细胞的功能,但它们的作用机制是完全不同的。少

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Udagawa N.,et al.: "Interleukin (IL) 6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors." J.Exp.Med.182. 1461-1468 (1995)
Udakawa N.,et al.:“破骨细胞分化的白细胞介素 (IL) 6 诱导取决于成骨细胞上表达的 IL-6 受体,而不是破骨细胞祖细胞上表达的 IL-6 受体。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suda T.,et al.: "Modulation of osteoclast differentiation : Update 1995." Endocrine Rev.Monographs. 4. 266-270 (1995)
Suda T. 等人:“破骨细胞分化的调节:1995 年更新。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Zhang, D. et al.: "The small GTP-binding protein, rho p21, is involved in bone resorption by regulating estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow." J. Cell Sci.108. 2285-2292 (1995)
张 D. 等人:“小 GTP 结合蛋白 rho p21 通过调节雌激素缺乏刺激小鼠骨髓中的 B 淋巴细胞生成来参与骨吸收。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suda,T.et al.: "The role of gravity in chick embryogenesis." FEBS Lett.340. 34-38 (1994)
Suda,T.et al.:“重力在鸡胚胎发生中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Wada,S.et al.: "Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells." J Bone Miner.Res.9. 1705-1712 (1994)
Wada,S.et al.:“糖皮质激素对小鼠破骨细胞样多核细胞中降钙素受体的调节。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUDA Tatsuo其他文献

SUDA Tatsuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUDA Tatsuo', 18)}}的其他基金

A study of cross-talk between the expression mechanisms of osteoclast differentiation factor (ODF) and osteoclastogenesis inhibitory factor (OCIF)
破骨细胞分化因子(ODF)与破骨细胞生成抑制因子(OCIF)表达机制的交叉研究
  • 批准号:
    15390465
  • 财政年份:
    2003
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The roles of nuclear transcription factors in calcium homeostasis
核转录因子在钙稳态中的作用
  • 批准号:
    10307046
  • 财政年份:
    1998
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Pathogenesis of bone loss due to estrogen deficiency : Relationship between increased B-lymphopoiesis and bone resorption.
雌激素缺乏引起的骨质流失的发病机制:B 淋巴细胞生成增加与骨吸收之间的关系。
  • 批准号:
    08407060
  • 财政年份:
    1996
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of osteoporosis induced by estrogen deficiency.
雌激素缺乏所致骨质疏松的分子机制。
  • 批准号:
    06404067
  • 财政年份:
    1994
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Molecular aspects of vitamin D metabolism and action
维生素 D 代谢和作用的分子方面
  • 批准号:
    04404072
  • 财政年份:
    1992
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Basic study on the risk factors of osteoporosis.
骨质疏松症危险因素的基础研究。
  • 批准号:
    02454429
  • 财政年份:
    1990
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Establishment of the screening methods for bone-resorbing factors using in vitro osteoclast formation system.
体外破骨细胞形成系统筛选骨吸收因子方法的建立
  • 批准号:
    01870078
  • 财政年份:
    1989
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Two step model for the fusion of macrophages induced by 1alpha, 25-dihydroxyvitamin D_3
1α,25-二羟基维生素D_3诱导巨噬细胞融合的两步模型
  • 批准号:
    63480414
  • 财政年份:
    1988
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Development of new assay systems for examining the relation between osteoblasts and osteoclasts, and identification of new factors controlling bone metabolism
开发新的检测系统来检查成骨细胞和破骨细胞之间的关系,并鉴定控制骨代谢的新因素
  • 批准号:
    61870074
  • 财政年份:
    1986
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Mechanisms of Fusion of Macrophages Induced by 1 ,25(OH)_2D_3
1 ,25(OH)_2D_3诱导巨噬细胞融合的机制
  • 批准号:
    60440086
  • 财政年份:
    1985
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

Elucidation of bone resorption mechanism around implants caused by microgap dissection and establishment of suppression method
微间隙剥离引起种植体周围骨吸收机制的阐明及抑制方法的建立
  • 批准号:
    22K10080
  • 财政年份:
    2022
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2022
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of bone resorption in the cancer microenvironment.
癌症微环境中的骨吸收机制。
  • 批准号:
    22K10145
  • 财政年份:
    2022
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Secretory mechanism of GMSC derved exosomes and suppression of bone resorption by internalizing miRNA
GMSC 衍生的外泌体的分泌机制和通过内化 miRNA 抑制骨吸收
  • 批准号:
    21K21017
  • 财政年份:
    2021
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10295620
  • 财政年份:
    2021
  • 资助金额:
    $ 6.59万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2021
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Discovery Grants Program - Individual
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10673929
  • 财政年份:
    2021
  • 资助金额:
    $ 6.59万
  • 项目类别:
A new model for spatio-temporal coupling of bone formation and bone resorption governed by osteoclasts
破骨细胞控制的骨形成和骨吸收时空耦合的新模型
  • 批准号:
    10905262
  • 财政年份:
    2020
  • 资助金额:
    $ 6.59万
  • 项目类别:
The Myokine Irisin Modulates Bone Resorption via Stimulation of Osteoclastogenesis
肌动素鸢尾素通过刺激破骨细胞生成调节骨吸收
  • 批准号:
    10228556
  • 财政年份:
    2020
  • 资助金额:
    $ 6.59万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2020
  • 资助金额:
    $ 6.59万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了